s

Alienum phaedrum torquatos nec eu, vis detraxitssa periculiser ex, nihil expetendis in mei eis an pericula es aperiri deprecatis.

Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO

Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO

This randomized clinical trial illustrates the 2-year effectiveness of laser-induced chorioretinal anastomosis procedure also intravitreal ranibizumab treatment versus sham procedure also intravitreal ranibizumab treatment for individuals with macular edema brought on by central retinal vein occlusion.

No Comments

Post A Comment